Hove Anders D
CIK 0001365618 Name as filed on the most recent filing
Filed as Hove Anders D (22)
38 transaction lines · from 22 filings · filed 2006-10-25 to 2025-05-19 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
- ISSUER OnKure Therapeutics, Inc. 1 filings
- ISSUER Inspire Medical Systems, Inc. 1 filings
- ISSUER Anacor Pharmaceuticals, Inc. 13 filings
- ISSUER Edge Therapeutics, Inc. 1 filings
- ISSUER Avalanche Biotechnologies, Inc. 1 filings
- ISSUER Chelsea Therapeutics International, Ltd. 2 filings
- ISSUER Alimera Sciences Inc 1 filings
- ISSUER World Heart Corp 1 filings
- ISSUER Trubion Pharmaceuticals, Inc 1 filings
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
31 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2025-05-15 |
OnKure Therapeutics, Inc. OKUR |
P, Open-market purchase | 1,129,730 acquired | 1.85 | 2,090,000.50 | Form 4, filing 0000950170-25-074459 | |
| 2025-05-15 |
OnKure Therapeutics, Inc. OKUR |
P, Open-market purchase | 270,270 acquired | 1.85 | 499,999.50 | Form 4, filing 0000950170-25-074459 | |
| 2018-05-07 |
Inspire Medical Systems, Inc. INSP |
P, Open-market purchase | 125,000 acquired | 16.00 | 2,000,000.00 | Form 4, filing 0001104659-18-031864 | |
| 2016-05-16 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 199,865 disposed | 99.41 | 19,868,579.65 | Form 4, filing 0001365618-16-000009 | |
| 2016-05-16 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 81,631 disposed | 100.60 | 8,212,078.60 | Form 4, filing 0001365618-16-000009 | |
| 2016-05-16 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 72,385 disposed | 98.93 | 7,161,048.05 | Form 4, filing 0001365618-16-000009 | |
| 2016-04-08 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 3,868 disposed | 70.05 | 270,953.40 | Form 4, filing 0001365618-16-000007 | |
| 2016-04-08 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 400 disposed | 71.40 | 28,560.00 | Form 4, filing 0001365618-16-000007 | |
| 2016-04-07 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 102,760 disposed | 70.33 | 7,227,110.80 | Form 4, filing 0001365618-16-000007 | |
| 2016-04-07 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 99,981 disposed | 71.44 | 7,142,642.64 | Form 4, filing 0001365618-16-000007 | |
| 2016-04-07 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 13,000 disposed | 72.15 | 937,950.00 | Form 4, filing 0001365618-16-000007 | |
| 2016-04-07 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 6,820 disposed | 75.57 | 515,387.40 | Form 4, filing 0001365618-16-000007 | |
| 2016-04-07 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 2,272 disposed | 73.29 | 166,514.88 | Form 4, filing 0001365618-16-000007 | |
| 2016-04-07 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 200 disposed | 74.13 | 14,826.00 | Form 4, filing 0001365618-16-000007 | |
| 2015-12-15 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 900,000 disposed | 111.25 | 100,125,000.00 | Form 4, filing 0001365618-15-000006 | |
| 2015-12-11 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 40,000 disposed | 117.36 | 4,694,400.00 | Form 4, filing 0001365618-15-000005 | |
| 2015-11-10 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 100,295 disposed | 103.60 | 10,390,562.00 | Form 4, filing 0001365618-15-000004 | |
| 2015-10-06 |
Edge Therapeutics, Inc. EDGE |
P, Open-market purchase | 450,000 acquired | 11.00 | 4,950,000.00 | Form 4, filing 0001140361-15-037182 | |
| 2014-09-26 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 20,000 disposed | 25.00 | 500,000.00 | Form 4, filing 0001365618-14-000004 | |
| 2014-09-19 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 738,500 disposed | 24.87 | 18,366,495.00 | Form 4, filing 0001365618-14-000003 | |
| 2014-09-18 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 1,500 disposed | 24.87 | 37,305.00 | Form 4, filing 0001365618-14-000003 | |
| 2014-09-16 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 75,000 disposed | 24.99 | 1,874,250.00 | Form 4, filing 0001365618-14-000002 | |
| 2014-09-12 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 15,000 disposed | 24.98 | 374,700.00 | Form 4, filing 0001365618-14-000002 | |
| 2014-08-05 |
Avalanche Biotechnologies, Inc. AAVL |
P, Open-market purchase | 400,000 acquired | 17.00 | 6,800,000.00 | Form 4, filing 0001495384-14-000004 | |
| 2013-11-15 |
Anacor Pharmaceuticals, Inc. ANAC |
S, Open-market sale | 150,000 disposed | 14.06 | 2,109,000.00 | Form 4, filing 0001365618-13-000002 | |
| 2012-09-20 |
Anacor Pharmaceuticals Inc ANAC |
S, Open-market sale | 19,273 disposed | 6.30 | 121,456.52 | Form 4, filing 0001365618-12-000006 | |
| 2012-09-14 |
Anacor Pharmaceuticals Inc ANAC |
S, Open-market sale | 35,000 disposed | 6.51 | 227,804.50 | Form 4, filing 0001365618-12-000005 | |
| 2012-09-13 |
Anacor Pharmaceuticals Inc ANAC |
S, Open-market sale | 15,000 disposed | 6.56 | 98,329.50 | Form 4, filing 0001365618-12-000004 | |
| 2012-09-11 |
Anacor Pharmaceuticals Inc ANAC |
S, Open-market sale | 10,177 disposed | 6.64 | 67,602.76 | Form 4, filing 0001365618-12-000004 | |
| 2011-02-02 |
Chelsea Therapeutics International, Ltd. CHTP |
P, Open-market purchase | 75,000 acquired | 5.00 | 374,992.50 | Form 4, filing 0001458177-11-000002 | |
| 2010-11-30 |
Anacor Pharmaceuticals Inc ANAC |
P, Open-market purchase | 600,000 acquired | 5.00 | 3,000,000.00 | Form 4, filing 0001365618-10-000007 | |
| 2010-09-20 |
Chelsea Therapeutics International, Ltd. CHTP |
S, Open-market sale | 83,691 disposed | 6.30 | 527,211.45 | Form 4, filing 0001458177-10-000001 | |
| 2010-09-20 |
Chelsea Therapeutics International, Ltd. CHTP |
S, Open-market sale | 15,309 disposed | 6.30 | 96,439.05 | Form 4, filing 0001458177-10-000001 | |
| 2010-04-27 |
Alimera Sciences Inc ALIM |
P, Open-market purchase | 306,071 acquired | 11.00 | 3,366,781.00 | Form 4, filing 0001365618-10-000004 | |
| 2010-01-21 |
World Heart Corp WHRT |
P, Open-market purchase | 388,350 acquired | 5.15 | 2,000,002.50 | Form 4, filing 0001365618-10-000002 | |
| 2006-10-23 |
Trubion Pharmaceuticals, Inc TRBN |
P, Open-market purchase | 28,637 acquired | 13.00 | 372,281.00 | Form 4, filing 0001365618-06-000002 | |
| 2006-10-23 |
Trubion Pharmaceuticals, Inc TRBN |
P, Open-market purchase | 5,840 acquired | 13.00 | 75,920.00 | Form 4, filing 0001365618-06-000002 | |
| 2006-10-23 |
Trubion Pharmaceuticals, Inc TRBN |
P, Open-market purchase | 704 acquired | 13.00 | 9,152.00 | Form 4, filing 0001365618-06-000002 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- P, Open-market purchase
- Open-market purchase
- S, Open-market sale
- Open-market sale
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.
- Open-market purchase 7
- Open-market sale 24
- Option exercise 0
- Grant or award 0
- Tax withholding 0
- Disposition to the issuer 0
- In-the-money option exercise 0
How to cite this page
ebomi catalog. Hove Anders D, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001365618
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6